3627 results for «540»
3627 results
Peripheral interventions: the hidden key for complications
22 May 2025 – From EuroPCR 2025
Uncover the critical role of peripheral interventions in managing complications. This session shares case stories of lost stents, unusual TAVI access complications, percutaneous removal of misplaced devices, revascularisation of iatrogenic pseudoaneurysms, and challenges when multiple closure devices are insufficient.
High thrombus burden in STEMI
22 May 2025 – From EuroPCR 2025
This session addresses the management of high thrombus burden in STEMI patients. It reviews available tools and strategies for thrombus management, presents multiple case-based discussions illustrating treatment decisions, and explores the evolving role of thrombus aspiration in contemporary practice.
Is DCB a new valid option for coronary revascularisation?
22 May 2025 – From EuroPCR 2025
This session provides an in-depth evaluation of drug-coated balloons (DCB) as a valid option for coronary revascularisation. Topics include two-year follow-up comparisons between paclitaxel and sirolimus-coated balloons, clinical outcomes after bailout stenting post-DCB angioplasty, meta-analyses contrasting DCB and DES for large native coronary artery disease, and...
Innovative strategies for coronary interventions
22 May 2025 – From EuroPCR 2025
Explore innovative strategies in coronary interventions, including the EPIC26 sirolimus-eluting stent study, use of percutaneous ventricular assist devices in high-risk patients, the SCORE multicenter study on SeQuent SCB, DCB versus DES for ostial left circumflex lesions, and site-specific antithrombotic therapy outcomes from the DESyne BDS Plus...
Percutaneous And Non-fluoroscopic Procedures (PAN): promoting equality and radiation-free intervention
22 May 2025 – From EuroPCR 2025
Discover innovative non-fluoroscopic interventional techniques with the Percutaneous And Non-fluoroscopic Procedures (PAN) session. Learn how to perform radiation-free interventions using advanced technologies, assess their clinical equivalence to standard methods, and explore how these procedures may promote gender equality in interventional cardiology careers.
Emerging indications for TAVI in 2025
22 May 2025 – From EuroPCR 2025
Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.
TAVI and coronary artery disease
22 May 2025 – From EuroPCR 2025
Examine the evolving role of coronary artery disease assessment in TAVI patients. This session compares coronary tomography and angiography for pre-TAVI evaluation, reviews safety and effectiveness of CT angiography-based strategies, and introduces the UNICORN procedure for managing high coronary obstruction risk in complex TAVI scenarios including...
TAVI in women
22 May 2025 – From EuroPCR 2025
Focus on gender-specific considerations in TAVI with this session. Topics include timely management and referral disparities in women with severe aortic stenosis, early outcomes from the LANDMARK trial with latest-generation valves, insights from NAVULTRA comparing valve types, prosthesis-patient mismatch data, and gender differences in right ventricular...
Calcified coronaries: novel devices and techniques
22 May 2025 – From EuroPCR 2025
Gain expert insights into managing calcified coronary lesions with novel devices and techniques. Topics include the safety and efficacy of rotational atherectomy, the distal rail-tracking technique, impact of burr speed and duration, innovative scoring balloon designs, and the RODIN-CUT sequential cutting balloon angioplasty method for moderate-to-severe...
Innovations in transcatheter aortic valve devices and techniques
22 May 2025 – From EuroPCR 2025
Explore the latest advancements in transcatheter aortic valve devices and innovative procedural techniques. This session presents initial clinical experiences with new self-expandable valves in small annuli, safety and performance data from the GENESIS-II study on the Hydra valve, and up to 12-month outcomes from the Valvosoft...
CTO beyond the conventional: when new strategies come to the rescue
22 May 2025 – From EuroPCR 2025
Delve into advanced strategies for chronic total occlusion (CTO) beyond conventional methods. This session covers step-by-step re-entry techniques with electrified guidewires, approaches to CTO in small vessels, and indications and methods for occlusion of saphenous vein grafts, illustrated by detailed case discussions and key learnings.
Should STEMI treatment be related to specific clinical patient characteristics
22 May 2025 – From EuroPCR 2025
This session evaluates whether STEMI treatment should be tailored to specific clinical patient characteristics. It includes insights into STEMI management in very young patients, benefits of revascularisation of LAD non-culprit lesions in older AMI patients, clinical outcomes from the NAMI registry for young STEMI patients, and...
Integrating CT coronary angiography into your PCI practice
22 May 2025 – From EuroPCR 2025
Integrate CT coronary angiography into your PCI practice to enhance procedural planning and outcomes. This session covers practical CT-based approaches for guiding catheter selection, lesion analysis, and stenting strategy. Learn how to leverage CT imaging to anticipate plaque preparation needs in calcified lesions and optimize catheterization...
Understanding research: insights from a groundbreaking study
22 May 2025 – From EuroPCR 2025
Enhance your understanding of contemporary research in PCI versus CABG with this session. Learn foundational research principles, latest study findings, and how to translate evidence into clinical practice to improve patient communication and outcomes, bridging the gap between research and everyday cardiology care.
Procedural aspects of DCB PCI
22 May 2025 – From EuroPCR 2025
Delve into procedural aspects of drug-coated balloon (DCB) PCI with a focus on lesion preparation, antiplatelet therapy, and outcomes in real-world settings. This session reviews the impact of pre-dilatation balloons on de novo lesions, compares ticagrelor versus clopidogrel post-PCI with drug-eluting balloons, and discusses streamlined revascularization...
High-risk PCI in acute coronary syndrome
22 May 2025 – From EuroPCR 2025
Explore high-risk PCI strategies in acute coronary syndrome patients who are unsuitable for surgery. This session presents insights on Killip class influence, haemodynamic support with micro-axial flow pumps, disease progression patterns in complicated STEMI, and the prognostic value of QFR-guided functional SYNTAX scores in ACS management.
Beyond the intervention: outcomes of CTO PCI
22 May 2025 – From EuroPCR 2025
Discover long-term outcomes and practical insights into chronic total occlusion (CTO) PCI. This session presents real-world registry data, cost-effectiveness analyses, effects of successful revascularisation in reduced ejection fraction and heart failure patients, and specific outcomes in octogenarian populations.
Predictors outcome after tricuspid TEER: is there a perfect tool
22 May 2025 – From EuroPCR 2025
Examine predictors of outcome following tricuspid transcatheter edge-to-edge repair (TEER) in this focused session. Review meta-analyses on TEER efficacy, survival benefits in high-risk patients from the EuroTR registry, and prognostic value of MELD?XI score from the TRISPA registry. Learn about TRI.Fr eligibility criteria and validation of...
When things threaten to go wrong: navigating procedural complications
22 May 2025 – From EuroPCR 2025
Develop critical skills for managing procedural complications in interventional cardiology. This session focuses on the identification and real-time management of common adverse events such as coronary dissection, perforation, tamponade, and embolism. Learn how to utilize echocardiographic imaging to assist in complication recognition and support your team...
When mitral disease is not the only problem on mitral TEER patients
22 May 2025 – From EuroPCR 2025
Explore the multifaceted challenges in patients undergoing mitral TEER when additional mitral and tricuspid pathologies coexist. This session reviews data from the EXPANDed studies on tricuspid regurgitation post-mitral TEER, one-year outcomes based on cardiac damage extent, pulmonary hypertension dynamics, and the long-term mortality causes in this...
